Skip to main content

Webinar: What's New in the 2022 National Biodefense Strategy? Congressional and White House Perspectives

Public-Facing Webcasts + Symposiums

Thursday, November 17, 2022, 12:00 p.m. - 1:00 p.m. ET
Past Event

The White House released a long-awaited National Biodefense Strategy and implementation plan to better protect the U.S. from biological threats, whether natural, accidental or deliberate. This session will feature an intimate fireside chat and audience Q&A with Dr. Raj Panjabi who serves in the White House National Security Council as the Senior Director for Global Health Security and Biodefense. It will be recorded and later shared with registrants.

In the aftermath of the COVID-19 pandemic, monkeypox outbreak, and Russian threats to use chemical, biological and nuclear weapons, this new strategy comes at a very important time for the United States. Biodefense incorporates a wide range of activities across several federal departments. These functions include biosurveillance, threat monitoring and awareness, biological arms control and nonproliferation, counterterrorism, biosafety and biosecurity, the development of medical countermeasures, medical planning and preparedness, and response and recovery activities. How will this strategy better enable the federal government to protect the nation from future pandemics or other biological threats? And what can Congress do now to support its implementation?


Tom Inglesby, MD, Director, Johns Hopkins Center for Health Security

Opening Remarks
Senator Joni Ernst, MPA (R-IA) ( Invited)

Raj Panjabi, MD, Senior Director for Global Health Security and Biodefense, White House National Security Council

A Q&A session will follow the moderated panel.

Contact Info

Prarthana Vasudevan